CAPSULaser in Cases of Intumescent Cataract

December 4, 2025 updated by: Zagazig University

Evaluating the Safety and Advantages of Using Selective Laser Capsulotomy to Create Capsulorhexis in Cases Intumescent Cataract

evaluating the use of selective laser in doing capsulotomy in intumescent cataract

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Evaluating the safety and advantages of using selective laser capsulotomy for capsulorhexis creation in intumescent cataract

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
    • Jedda
      • Jeddah, Jedda, Saudi Arabia, 22233
        • Magrabi eye hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients with intumescent cataract and good pupil dilatation

Exclusion Criteria:

  • absence of corneal scaring

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: intumescent cataract
CAPSULaser
Procedure: CAPSULaser
doing capsulotomy using CAPSULaser
Device: capsulotomy
capsulorhexis using CAPSULaser

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To measure the actual size compared to result size as measured by slit lamp in mm
Time Frame: 3 months
To measure the actual size compared to result size as measured by slit lamp
3 months
Incidence and number of extended capsulorhexis to the total number of cases
Time Frame: 1 month
Incidence and number of extended capsulorhexis
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Zagazig University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 8, 2025

Primary Completion (Actual)

November 6, 2025

Study Completion (Actual)

November 6, 2025

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

December 4, 2025

First Posted (Actual)

December 5, 2025

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MEH-IRB# 432 - 7 - July -2025
  • Maghrabi eye hospitals (Other Identifier: Maghrabi eye hospitals)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intumescent Cataract

Clinical Trials on CAPSULaser

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe